WO2022202282A1 - Dispositif d'administration - Google Patents

Dispositif d'administration Download PDF

Info

Publication number
WO2022202282A1
WO2022202282A1 PCT/JP2022/009927 JP2022009927W WO2022202282A1 WO 2022202282 A1 WO2022202282 A1 WO 2022202282A1 JP 2022009927 W JP2022009927 W JP 2022009927W WO 2022202282 A1 WO2022202282 A1 WO 2022202282A1
Authority
WO
WIPO (PCT)
Prior art keywords
delivery device
needle
injection needle
irradiation
line light
Prior art date
Application number
PCT/JP2022/009927
Other languages
English (en)
Japanese (ja)
Inventor
善紀 米田
大貴 有馬
Original Assignee
テルモ株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by テルモ株式会社 filed Critical テルモ株式会社
Publication of WO2022202282A1 publication Critical patent/WO2022202282A1/fr

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A61M5/145—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons

Definitions

  • the present invention relates to a delivery device that delivers a delivery product such as a drug or medical device to an affected area in vivo.
  • a delivery device that delivers a drug is used to treat an affected area such as a tumor or a site suspected of being an affected area.
  • an ultrasonic image photoacoustic image
  • an ultrasonic signal obtained by transmitting and receiving ultrasonic waves (photoacoustic waves) to and from a needle.
  • the tip of the injection needle of the puncture device is curved outward from the axial direction, and the injection needle is rotated to change the puncture point to the tumor while injecting the drug.
  • Treatment methods are conceivable.
  • the injection needle can be rotated to direct the puncture end of the injection needle to different positions of the tumor, so that different positions of the tumor can be approached without changing the puncture site of the puncture device. Become.
  • the operator when inserting the injection needle into the tumor, in order to avoid the risk of damage to other tissues and blood vessels around the tumor, the operator should check the ultrasound image and check the tip of the injection needle and the tumor. It is necessary to grasp the positional relationship.
  • the ultrasonic waves transmitted from the ultrasonic probe In order to display the tip portion of the injection needle on the ultrasonic image, the ultrasonic waves transmitted from the ultrasonic probe must be irradiated so as to overlap a plane passing through the central axis of the injection needle.
  • the tip of the injection needle is curved and faces sideways, so depending on the bending direction of the injection needle, the puncture end may deviate from the ultrasonic irradiation area. .
  • the operator When the tip portion of the injection needle is not displayed on the ultrasound image, the operator tries to position the ultrasound probe in accordance with the bending direction of the injection needle, but the bending direction of the injection needle can be adjusted from outside the body. Correct placement of the ultrasound probe is difficult because there is no way to check.
  • a needle guide that holds the puncture device is typically attached to the ultrasound probe, and treatment is performed while simultaneously moving the ultrasound probe and the puncture device.
  • Patent Document 1 cannot easily grasp the correct arrangement position of the ultrasonic probe, and there is room for improvement.
  • At least one embodiment of the present invention has been made in view of the above circumstances. To provide a delivery device capable of ascertaining the correct arrangement position of an ultrasonic probe with respect to.
  • a delivery device is a delivery device that punctures from the surface of a living body to deliver a delivery product to an affected area in the living body, and has a first operation section and a lumen, and a distal end of the first operation section.
  • an outer cylinder extending along the longitudinal direction from the outer cylinder; a second operating part attached to the first operating part so as to be slidable in the longitudinal direction; , an injection needle extending along the longitudinal direction from the tip of the second operating portion; and a plane attached to at least one of the first operating portion and the second operating portion and passing through the central axis of the injection needle.
  • an irradiating unit that irradiates the surface of the living body with overlapping line lights.
  • the present invention it is possible to grasp the correct arrangement position of the ultrasonic probe with respect to the surface of the living body when confirming the behavior of the injection needle inserted into the living body and the position with respect to the affected part with the ultrasonic image. can.
  • FIG. 1 is a schematic side view of a delivery device according to this embodiment
  • FIG. FIG. 4 is a partial cross-sectional view showing a state before the injection needle is advanced in the delivery device according to the present embodiment
  • FIG. 4 is a partial cross-sectional view showing a state after the injection needle has advanced in the delivery device according to the present embodiment
  • FIG. 4 is a conceptual diagram of the delivery device according to the present embodiment, viewed from the side, in which line light is emitted from the irradiation unit.
  • FIG. 4 is a conceptual diagram of the delivery device according to the present embodiment, viewed from above, in which line light is emitted from the irradiation unit.
  • FIG. 10 is a partial cross-sectional view showing the configuration of the delivery device of Modification 1;
  • FIG. 11 is a partial cross-sectional view showing another form of the delivery device of Modification 1;
  • FIG. 11 is a partial cross-sectional view showing the configuration of the delivery device of Modification 2;
  • FIG. 11 is a schematic configuration diagram showing a usage example of the delivery device of Modification 2;
  • FIG. 11 is a schematic configuration diagram showing a usage example of the delivery device of Modification 2;
  • FIG. 11 is a schematic side view showing the configuration of the delivery device of Modification 3;
  • FIG. 11 is a partial cross-sectional view showing another form of the delivery device of Modification 3;
  • FIG. 20 is a schematic side view showing a state before rotation of the second operating portion in the delivery device of Modified Example 4;
  • FIG. 20 is a schematic side view showing a state after rotation of the second operating portion in the delivery device of Modification 4;
  • FIG. 12 is a conceptual diagram when the ultrasonic probe is arranged in the correct posture in the delivery device of Modification 5;
  • FIG. 12 is a conceptual diagram when the ultrasonic probe is arranged in a wrong posture in the delivery device of Modification 5;
  • FIG. 20 is a schematic side view showing a state before one injection needle is advanced in the delivery device of Modification 6;
  • FIG. 20 is a schematic side view showing a state after advancing one injection needle in the delivery device of Modification 6;
  • FIG. 11 is a schematic cross-sectional view of a delivery device of Modification 7;
  • the side where the delivery device 100 is inserted into the living body is defined as the "distal side", and the side opposite to the distal side (the side gripped by the operator) is defined as the “base end side”.
  • a portion including a certain range along the longitudinal direction (extending direction of the central axis Z of the delivery device 100) from the distal end (most proximal end) is referred to as a “distal portion”, and from the proximal end (most proximal end) in the longitudinal direction.
  • the part including the fixed range in be a "base end part.”
  • the delivery device 100 generally includes a first operating section 10, a second operating section 20, an outer cylinder 30, an injection needle 40, an irradiation section 50, Prepare.
  • the delivery device 100 is for delivering a predetermined delivery product (medicine or medical device) to an affected area in the living body through the injection needle 40 while being inserted into the living body.
  • the central axis A of the first operating section 10, the second operating section 20, the outer cylinder 30, and the central axis B of the injection needle 40 all coincide with the central axis Z of the delivery device 100 (see FIG. 2A).
  • the central axis Z coincides with the direction in which the delivery device 100 advances and retreats with respect to the biological surface S and the direction in which the second operation section 20 is pushed and pulled.
  • the central axis Z is also curved along the bending direction of the injection needle 40 (see FIG. 2B).
  • the first operating section 10 is composed of a hollow cylindrical member having a lumen 11, and an outer cylinder 30 is attached to the tip.
  • a lumen 11 of the first operating portion 10 communicates with a lumen 31 of the outer cylinder 30 .
  • a second operating portion 20 is housed inside the first operating portion 10 so as to be slidable along the longitudinal direction.
  • An irradiation unit 50 is arranged on the outer peripheral surface of the first operation unit 10 .
  • the second operation part 20 is composed of a hollow cylindrical member having a lumen 21, and an injection needle 40 is attached to the tip.
  • a lumen 21 of the second operating portion 20 communicates with a lumen 41 of the injection needle 40 .
  • the second operating portion 20 is housed in the lumen 11 of the first operating portion 10 so as to be slidable along the longitudinal direction. Therefore, the injection needle 40 can be advanced and retracted from the outer cylinder 30 along the long axis direction by pushing and pulling the second operation portion 20 .
  • the distance between the tip position of the second operation part 20 and the tip-side inner wall of the lumen 11 of the first operation part 10 is set according to the advance amount of the injection needle 40 . That is, as shown in FIG. 2A, in the state before the second operation part 20 slides, the distal end position of the second operation part 20 and the distal end side inner wall of the lumen 11 of the first operation part 10 are at least the advancing position. separated by an amount. Further, as shown in FIG. 2B , the second operating portion 20 slides toward the distal end side by the amount of advance after sliding, and the tip of the second operating portion 20 slides inside the first operating portion 10 . It will be in close proximity to the distal inner wall of the cavity 11 . In this state, the injection needle 40 advances from the outer cylinder 30 .
  • the second operating section 20 includes a push-pull section 22 and a hub section 23 on the proximal end side.
  • the push/pull part 22 is operated when performing a push/pull operation for advancing and retracting the injection needle 40 from the outer cylinder 30 .
  • the operator can advance the injection needle 40 from the outer tube 30 by pushing (sliding toward the distal end side) the push/pull portion 22 .
  • the operator can retract the injection needle 40 advanced from the outer tube 30 into the outer tube 30 by pulling the push/pull portion 22 (sliding toward the proximal side).
  • the hub portion 23 has a lumen that communicates with an opening formed on the proximal side.
  • the lumen of hub portion 23 communicates with lumen 41 of injection needle 40 via lumen 21 of second operation portion 20 . Therefore, lumen 41 of injection needle 40 can communicate with the outside via hub portion 23 .
  • Hub portion 23 functions as an introduction port for introducing a delivery product into injection needle 40 .
  • the hub portion 23 is used to attach, for example, a tip of a syringe or a tube for drug administration, or to insert a medical device.
  • the hub portion 23 is provided on the push/pull portion 22 on the base end side of the second operation portion 20 , but may be provided on the side surface side of the second operation portion 20 .
  • the outer peripheral surface of the second operation portion 20 may be provided with a marker portion that allows the bending direction of the injection needle 40 to be visually or tactilely confirmed. This allows the operator to insert the delivery device 100 into the living body while grasping the bending direction of the injection needle 40 in advance.
  • the second operation portion 20 has, on its outer peripheral surface, the extension length (puncture length) of the injection needle 40 from the outer cylinder 30 and the degree of curvature in the bending direction (the central axis of the needle body portion 42). It is preferable to provide a scale portion that allows the distance from B1 to the puncture end 43b to be visually or tactilely confirmed. This allows the operator to grasp the puncture length of the injection needle 40 with respect to the affected area and the degree of bending in the bending direction while the delivery device 100 is inserted into the living body.
  • the second operation unit 20 may be provided with a puncture length limiting mechanism (stopper) for limiting the puncture length of the injection needle 40 to a predetermined length.
  • stopper for limiting the puncture length of the injection needle 40 to a predetermined length.
  • the outer cylinder 30 is composed of a hollow tubular member having a lumen 31 that communicates from the distal end to the proximal end, and extends along the longitudinal direction from the distal end of the first operation section 10. .
  • a lumen 31 of the outer cylinder 30 communicates with a distal opening 32 on the distal side and communicates with a proximal opening 33 on the proximal side.
  • the proximal end opening 33 communicates with the lumen 11 of the first operating section 10 .
  • An injection needle 40 is housed in the lumen 31 of the outer cylinder 30 .
  • a non-invasive or minimally invasive material that can be used in the medical field can be applied. It is preferable to adopt a material with relatively high rigidity (stainless steel, titanium alloy, CoCr alloy, etc.).
  • the outer cylinder 30 is inserted along an introduction device such as a cannula that has been previously introduced into the living body.
  • an introduction device such as a cannula that has been previously introduced into the living body.
  • the outer cylinder 30 has a sharp needle-like tip, it can be inserted into the affected part by puncturing from the living body surface S without using an introduction device.
  • the outer cylinder 30 may be provided with a fixing member on its outer peripheral surface for position fixing on the living body surface S during the procedure. As a result, the operator can fix the position of the outer tube 30 during the procedure and accurately puncture the injection needle 40 into the target site of the affected area.
  • the injection needle 40 is composed of a hollow cylindrical member having a lumen 41, and extends from the tip of the second operating portion 20 along the longitudinal direction.
  • the injection needle 40 includes a needle body portion 42 , a needle tip portion 43 and a curved portion 44 .
  • the needle body portion 42 and the needle tip portion 43 communicate with each other through the lumen 41 .
  • the needle main body portion 42 is composed of a hollow tubular member, and the proximal end thereof is connected to the distal end of the second operating portion 20 . Therefore, lumen 41 of injection needle 40 communicates with lumen 21 of second operation section 20 . The distal end of the needle main body 42 is connected to the proximal end of the needle distal end portion 43 .
  • the needle tip 43 has a sharp puncture end 43b with an opening 43a at the tip. At least part of the needle tip portion 43 advances from the outer cylinder 30 into the living body as the second operation portion 20 slides. Further, the needle tip portion 43 has a curved portion 44 and is configured to be deformable into a shape in which at least a portion thereof is curved sideways.
  • the curved portion 44 constitutes at least a portion or substantially the entirety of the needle tip portion 43, and gradually extends from the tip of the needle body portion 42 toward the opening 43a of the needle tip portion 43 toward the central axis A ( It has a shape bent in a direction (radial direction with respect to the central axis A of the outer cylinder 30) away from the central axis B1) of the needle main body 42).
  • the curved portion 44 may be set in the same region as the needle tip portion 43, as shown in FIG. 2A.
  • the curved portion 44 maintains its curved shape when the needle tip portion 43 advances from the outer cylinder 30, as shown in FIG. 2B.
  • the bending portion 44 has a lower rigidity than the outer cylinder 30, when the needle tip portion 43 is accommodated in the outer cylinder 30, as shown in FIG. Thereby, the curved shape is corrected to a substantially straight state.
  • the curved portion 44 is configured to have a curved shape in advance, and is also a guide member that guides the needle distal end portion 43 extending from the distal end opening portion 32 of the outer cylinder 30 in an oblique direction (a direction away from the central axis B1 of the needle main body portion 42). Any configuration that bends the needle tip portion 43 when it advances from the outer tube 30 , such as a configuration that curves by a needle (not shown), may be used.
  • the injection needle 40 may have a configuration in which the opening 43a of the puncture end 43b is sealed and a plurality of holes are provided on the side surface of the needle tip portion 43. .
  • the material of the injection needle 40 is not particularly limited as long as it is a material that is applied to a puncture needle that is attached to a known syringe used in the medical field. Applicable.
  • the irradiation section 50 is attached to the outer peripheral surface of the first operation section 10 .
  • the irradiating unit 50 irradiates a linear beam of light having a predetermined wavelength (hereinafter referred to as “line light L”).
  • the irradiation unit 50 is not particularly limited as long as it is a light source that can irradiate the line light L. However, in order to be able to linearly irradiate the line light L onto the living body surface S having a three-dimensional gradient, it is possible to It is preferred to use a high laser light source. Further, since the line light L irradiates the living body surface S, it is preferable that the line light L has a greenish color tone as a complementary color.
  • the irradiation unit 50 passes through the central axis B of the injection needle 40 (more specifically, the central axis of the lumen 41 coincides with the central axis B1 of the needle main body 42 and the central axis B2 of the needle tip portion 43 of the injection needle 40).
  • Line light L is applied so as to overlap the plane.
  • the living body surface S is irradiated with the line light L emitted from the irradiation unit 50 .
  • the line light L is irradiated so as to overlap the plane passing through the central axis B of the injection needle 40, so that the needle tip portion 43 of the injection needle 40 inserted into the living body is curved. Illuminated from the direction side.
  • the operator arranges the wave transmission surface 210 of the ultrasonic probe 200 along the line light L, the operator can enter the irradiation area of the ultrasonic waves U emitted from the wave transmission surface 210 at least from the outer cylinder 30. Needle tip 43 of infusion needle 40 will be present. Therefore, the operator can deliver the delivery product to the target position of the affected area by viewing the ultrasonic image showing the entirety of the needle tip 43 advanced from the outer cylinder 30 .
  • the irradiation unit 50 may include a light guide member such as a diffusion plate or a reflection plate at the irradiation port so as to irradiate the line light L at a predetermined irradiation angle (preferably 30 degrees or more, more preferably 45 degrees or more). good.
  • a predetermined irradiation angle preferably 30 degrees or more, more preferably 45 degrees or more.
  • a treatment method using the delivery device 100 according to this embodiment will be described.
  • the following description shows an example of a treatment in which a drug (liquid drug) for treating a tumor in an affected area is administered to the tumor at three sites as a delivered product.
  • the operator prepares a drug to be administered to the tumor in the affected area, and primes the syringe and injection needle 40 for injecting the drug.
  • the operator operates the ultrasonic probe 200 to confirm the central position of the patient's tumor with the ultrasonic diagnostic apparatus, and determines the puncture route from the biological surface S to the tumor.
  • the operator After disinfecting the puncture site and applying local anesthesia, the operator inserts (punctures) the outer cylinder 30 of the delivery device 100 toward the tumor under echo guidance. At this time, the operator positions the ultrasonic probe 200 on the body surface so as to visualize the tumor, and extends the distal end of the outer cylinder 30 of the delivery device 100 to a position where it reaches the outer surface of the tumor. Insert barrel 30 . At this time, the living body surface S is irradiated with the line light L emitted from the irradiation unit 50 . By piercing the ultrasound probe 200 so that the line light L is irradiated in parallel with the ultrasound probe 200, the needle tip portion 43 of the injection needle 40 advanced from the outer cylinder 30 can be displayed on the ultrasound image. .
  • the operator punctures the injection needle 40, there are directions in which the tumor cannot be confirmed due to interference with the ultrasonic waves U by air in the bones and lungs and the viewing angle of the ultrasonic probe 200.
  • the direction of puncture into the tumor can also be oriented prior to puncturing 40 into the tumor. While positioning the ultrasonic probe 200 based on the line light L emitted from the irradiation unit 50, the operator determines a plurality of puncture directions that can be confirmed by echo, and marks the biological surface S. If you do, you can proceed with the procedure smoothly.
  • the operator pushes the push/pull unit 22 while checking the interface of the tumor, and moves the needle tip 43 of the injection needle 40 to the outer tube 30 . advance from and puncture the tumor.
  • the operator operates the syringe or syringe pump to administer the drug. As a result, the first administration is completed, and the drug, which is the product to be delivered, is delivered to the affected tumor.
  • the operator pulls the push/pull part 22 to retract the injection needle 40 into the outer cylinder 30 .
  • the operator removes the delivery device 100 from the needle guide, rotates the delivery device 100 in a predetermined direction, and moves the bending direction of the injection needle 40 to the second puncture site.
  • the line light L emitted from the irradiation unit 50 follows the rotation of the device and is emitted in a direction corresponding to the bending direction of the injection needle 40 . Therefore, the line light L is irradiated with a trajectory different from the orientation of the first puncture.
  • the operator positions the arrangement position of the ultrasonic probe 200 in the second puncture direction based on the line light L irradiated on the living body surface S.
  • the operator can roughly grasp the behavior of the injection needle 40 .
  • the operator tilts the injection needle 40 forward and backward with the wave transmission surface 210 of the ultrasound probe 200 along the line light L. It is also possible to find a posture in which the behavior can be grasped more precisely.
  • the drug which is the product to be delivered, is delivered to a site different from the first delivery to the affected tumor.
  • the operator pulls the push/pull part 22 to retract the injection needle 40 into the outer cylinder 30 .
  • an operation such as opening a three-way stopcock in the administration route may be performed in order to remove the pressure in the administration route increased by the administration.
  • the operator rotates delivery device 100 in a predetermined direction to move injection needle 40 in the curved direction to the third puncture site.
  • the line light L emitted from the irradiation unit 50 follows the rotation of the device and is emitted in a direction corresponding to the bending direction of the injection needle 40 . Therefore, the line light L is irradiated with a trajectory different from the directions of the first and second punctures.
  • the operator positions the arrangement position of the ultrasonic probe 200 with respect to the third puncture direction with reference to the line light L irradiated on the living body surface S.
  • the drug which is the product to be delivered, is delivered to a site different from the first and second delivery to the affected tumor.
  • the operator pulls the push/pull part 22 to retract the injection needle 40 into the outer cylinder 30 .
  • the delivery device 100 is removed from the living body to complete the procedure.
  • Modification 1 is a configuration in which the outer cylinder 30 is attached so as to be rotatable about the long axis of the first operating portion 10, as shown in FIGS. 4A and 4B.
  • the outer cylinder 30 is provided with a collar portion 34 along the entire circumference of the outer peripheral surface on the proximal end side of the outer cylinder 30 .
  • An annular support portion 12 that rotatably holds the collar portion 34 is provided at the tip of the first operation portion 10 .
  • the outer cylinder 30 extends from the base end side of the outer cylinder 30 along the outer peripheral surface of the first operating portion 10, and the distal end thereof is the first operating portion.
  • An extension 35 is provided that slidably engages an annular groove 13 formed in the outer peripheral surface of portion 10 .
  • the delivery device 100 of Modified Example 1 by rotatably attaching the outer cylinder 30 to the first operation section 10, when the injection needle 40 is rotated, the outer cylinder 30 does not rotate with the injection needle 40 and is inserted. The state (insertion posture) is maintained. Therefore, in Modification 1, damage due to friction with the surrounding living tissue that may occur due to rotation of the outer cylinder 30 is prevented.
  • Modification 2 has two irradiating units 50, and is characterized by its arrangement position.
  • the delivery device 100 of Modification 2 has a first irradiation position where the line light L1 can be irradiated along the central axis B of the injection needle 40 from the bending direction side of the needle tip portion 43, and the outer peripheral surface of the first operation portion 10.
  • a second irradiation position where the line light L2 can be irradiated along the central axis B of the injection needle 40 from the side opposite to the bending direction side of the needle tip portion 43, which is a position facing the first irradiation position in the radial direction. It is configured to be Both the first irradiation position and the second irradiation position are positions where the line light L can be irradiated so as to overlap the plane passing through the needle main body 42 and the needle tip 43 of the injection needle 40 .
  • the delivery device 100 of Modification 2 can irradiate the line light L1 and the line light L2 in two directions, ie, the bending direction of the needle distal end portion 43 of the injection needle 40 and the opposite side of the bending direction. Therefore, when inserting the delivery device 100 into the living body, the operator places the ultrasonic probe 200 on the living body surface S along the line light L1 emitted from the first irradiation position as shown in FIG. 6A. In addition, when the operator cannot confirm the needle tip portion 43 of the injection needle 40 at the position of the line light L1 irradiated from the first irradiation position due to obstacles such as bones in the living body and air in the lungs, as shown in FIG. As shown, the ultrasound probe 200 can be placed on the biological surface S along the line light L2 irradiated from the second irradiation position. Therefore, the operator has a higher degree of freedom in positioning the ultrasound probe 200, which facilitates treatment.
  • Modification 3 As shown in FIGS. 7A and 7B, the second operation unit 20 is rotatably attached to the first operation unit 10, and the irradiation unit 50 can follow the rotation operation of the second operation unit 20. It is a configuration that The delivery device 100 of Modification 3 is configured to rotate the second operation section 20 to change the puncture direction of the injection needle 40 with respect to the affected area.
  • the delivery device 100 of Modified Example 3 has a configuration in which the irradiation section 50 is attached to the outer peripheral surface of the second operation section 20 by joining it, as shown in FIG. 7A.
  • the delivery device 100 of Modification 3 is provided with a notch 14 on the outer peripheral surface of the first operation section 10 so that the irradiation section 50 can be rotated as the position of the irradiation section 50 is changed.
  • a part of the outer peripheral surfaces of the second operating part 20 and the injection needle 40 and the irradiation part 50 are exposed from the first operating part 10 .
  • the irradiation section 50 when the second operation section 20 is rotated to change the puncture direction of the injection needle 40 with respect to the affected area, the irradiation section 50 also rotates so as to follow the rotational movement.
  • the delivery device 100 of Modification 3 can adopt the form shown in FIG. 7B.
  • the delivery device 100 of Modification 3 has a configuration in which the irradiation section 50 is attached to the outer peripheral surface of the second operation section 20 by being joined thereto.
  • the irradiation unit 50 is arranged on the outer peripheral surface of the second operation unit 20 while being accommodated inside the first operation unit 10 .
  • the delivery device 100 of Modified Example 3 is provided with a window portion 15 through which the line light L emitted from the irradiation section 50 is transmitted as the arrangement position of the irradiation section 50 is changed.
  • the window part 15 is arranged at a position facing the irradiation port of the irradiation part 50 on the distal end side of the first operation part 10 .
  • the window part 15 is made of a colorless or colored transparent material (glass, acrylic, etc.) having translucency that does not obstruct the line light L as much as possible. Further, the refractive index of the window 15 may be adjusted so that the irradiation angle of the line light L is wide.
  • the delivery device 100 of Modified Example 3 when the injection needle 40 is rotated, the outer cylinder 30 is maintained in a state of being inserted into the living body (insertion posture). Therefore, the delivery device 100 of Modification 3 can prevent damage due to friction with the surrounding living tissue that may occur when the outer cylinder 30 rotates. In addition, since the irradiation unit 50 rotates along with the rotation operation of the second operation unit 20 , the line light L can be irradiated following the bending direction of the needle distal end portion 43 of the injection needle 40 .
  • the delivery device 100 of Modification 3 has a configuration in which the irradiation unit 50 can follow the rotational movement of the second operation unit 20 in a configuration in which the second operation unit 20 is rotated to change the orientation of the injection needle 40 with respect to the affected area.
  • the delivery device 100 is not limited to the configuration shown in FIGS. 7A and 7B. It is also possible to adopt a configuration in which it is attached so as to follow only rotational movement without following movement in the forward/backward direction (front-rear direction).
  • Modification 4 as shown in FIGS. 8A and 8B, includes two irradiation units 50, one irradiation unit 50 (first irradiation unit 51) is attached to the outer peripheral surface of the first operation unit 10, and the other It is configured such that the irradiation unit 50 (second irradiation unit 52 ) can follow the rotation operation of the second operation unit 20 on the outer peripheral surface of the second operation unit 20 .
  • the delivery device 100 of Modification 4 is configured to rotate the second operation part 20 to change the puncture direction of the injection needle 40 with respect to the affected area, as in the modification 3.
  • FIG. 8A and 8B includes two irradiation units 50, one irradiation unit 50 (first irradiation unit 51) is attached to the outer peripheral surface of the first operation unit 10, and the other It is configured such that the irradiation unit 50 (second irradiation unit 52 ) can follow the rotation operation of the second operation unit 20 on the outer peripheral surface of the second operation unit 20 .
  • the first irradiation unit 51 and the second irradiation unit 52 are irradiated from the first irradiation unit 51 in a state before the second operation unit 20 is rotated with respect to the first operation unit 10, as shown in FIG. 8A.
  • the line light L3 emitted from the second irradiation unit 52 and the line light L4 emitted from the second irradiation unit 52 are attached at positions where the line light L4 is superimposed on the living body surface S. Both the line light L3 and the line light L4 are irradiated so as to overlap a plane passing through the central axis B of the injection needle 40 .
  • the second irradiation unit 52 rotates following the rotation of the second operation unit 20, as shown in FIG. 8B.
  • the line light L ⁇ b>4 emitted from the second irradiation unit 52 is applied so as to overlap a plane passing through the central axis B of the injection needle 40 .
  • the line light L3 emitted from the first irradiation section 51 and the line light L4 emitted from the second irradiation section 52 are emitted. is superimposed. This allows the operator to arrange the ultrasound probe 200 along the two line lights. Further, when the bending direction of the injection needle 40 is changed by rotating the second operating section 20 , the second irradiation section 52 also rotates following the rotational movement of the second operating section 20 . Accordingly, after rotating the second operation unit 20 , the operator can arrange the ultrasound probe 200 along the line light L4 emitted from the second irradiation unit 52 .
  • the ultrasonic probe 200 can be accurately grasped.
  • the position where the injection needle was first punctured and then the injection needle It is possible to visually confirm how far apart the positions are.
  • the line light L3 emitted from the first irradiation unit 51 and the line light L4 emitted from the second irradiation unit 52 can be easily distinguished. Attributes (hue, lightness, saturation) and illumination width may be changed.
  • Modification 5 is a configuration in which two types of line light L emitted from the irradiation unit 50 are emitted, as shown in FIGS. 9A and 9B.
  • the irradiation unit 50 includes a first line light LA for alignment of the wave transmission surface 210 indicating the arrangement position of the ultrasonic probe 200 with respect to the biological surface S, and the first line light LA arranged on the biological surface S Second line light beams LB (LB1, LB2) for angle adjustment for correcting the inclination of the wave transmission surface 210 with respect to the biological surface S of the ultrasound probe 200 are emitted.
  • the second line beams LB1 and LB2 are emitted substantially parallel to the first line beam LA with a predetermined gap therebetween.
  • the interval of the second line light LB with respect to the first line light LA is set to the extent that the deviation of the tilt of the ultrasonic probe 200 can be confirmed.
  • the operator adjusts the inclination so that the ultrasound probe 200 is not covered with the second line light LB (LB1 or LB2). By doing so, the ultrasonic probe 200 can be positioned correctly.
  • the irradiation unit 50 may be configured to irradiate the second line light LB along both side edges of the first line light LA. That is, the first line light LA may be surrounded by the second line light LB.
  • Modification 6 provides a plurality of injection needles 40, and each of the injection needles 40 is configured to be independently advanceable and retractable.
  • the delivery device 100 of Modification 6 has an irradiation section 50 on the outer peripheral surface of the outer cylinder 30 corresponding to the bending direction of the plurality of injection needles 40 .
  • the bending directions of the three injection needles 40 are set at a predetermined angle (when viewed from the axial direction) in the circumferential direction of the second operation section 20.
  • the injection needle 40 is positioned at 0°, 120°, 240° clockwise, and the base end of the injection needle 40 is connected to each of the push-pull portions 22 divided into three. Further, the hub portion 23 is provided in each of the pushing/pulling portions 22 divided into three.
  • the injection needle 40 connected to the operated push-pull section 22 moves toward the outer cylinder 30 . Advance or retreat. Further, when the operator simultaneously pushes and pulls the three divided push-pull portions 22, the three injection needles 40 can be advanced and retracted at the same time.
  • the injection needle 40 can be punctured at different positions of the affected area without rotating the second operation section 20 or rotating the delivery device 100 itself.
  • the delivery device 100 of Modification 6 includes an irradiation unit 50 that irradiates each injection needle 40 with line light L so as to overlap a plane passing through the central axis B of the injection needle 40 . Therefore, when the operator pushes and pulls the injection needle 40 individually, the operator can arrange the ultrasonic probe 200 along the line light L emitted from the corresponding irradiation unit 50 .
  • a plurality of injection needles 40 may be provided at the distal end of one second operating portion 20, and may be configured to move forward and backward simultaneously when the second operating portion 20 is pushed and pulled.
  • the operator can confirm the advancing direction of each injection needle 40 by relying on each line light L in advance, and simultaneously puncture while looking at the needle closest to the edge of the tumor. Also, after puncturing, the operator can confirm that the other injection needles 40 are not protruding from the tissue based on each line light L.
  • Modification 7 is provided with reflecting portions 60 for increasing the difference in acoustic impedance with the surroundings on the outer peripheral surfaces of the distal end side of the outer cylinder 30 and the distal end side of the injection needle 40 (mainly in the vicinity of the needle distal end portion 43). Configuration.
  • the reflecting part 60 is provided on the outer peripheral surface of the outer cylinder 30 on the distal end side and the outer peripheral surface of the needle distal end portion 43 of the injection needle 40 .
  • the reflecting part 60 has the effect of improving the reflection efficiency of the ultrasonic waves U and improving the visibility on the ultrasonic image.
  • the reflecting part 60 has a shape that improves the reflection efficiency of the ultrasonic waves U.
  • the reflecting portion 60 is configured with a concave groove (concave shape), a ridge or a plurality of projections (convex shape), or an uneven shape such as a satin finish.
  • the reflecting part 60 is preferably provided on the outer peripheral surface corresponding to the bending direction so that the bending direction of the injection needle 40 can be confirmed on the ultrasonic image.
  • the visibility of the outer cylinder 30 and the injection needle 40 is improved for the operator on the ultrasonic image, so that it is easy for the operator to position the insertion position and the puncture site with respect to the affected area during insertion into the living body. becomes.
  • the delivery device 100 is a device that punctures the biological surface S to deliver a delivery product to an affected area in the living body, and has the first operation section 10 and the lumen 31. , an outer cylinder 30 extending along the longitudinal direction from the tip of the first operating part 10, a second operating part 20 attached to the first operating part 10 so as to be slidable in the longitudinal direction, and an outer cylinder Injection needle 40 which is housed in lumen 31 of 30 so as to be advanceable and retractable and extends along the longitudinal direction from the distal end of second operating section 20 , and at least one of first operating section 10 and second operating section 20 and an irradiating unit 50 that irradiates the living body surface S with line light L that is attached and overlaps a plane passing through the central axis B of the injection needle 40 .
  • the injection needle 40 also has a needle distal end portion 43 having an opening 43a at the distal end, and a hollow needle main body portion 42 extending from the proximal end of the needle distal end portion 43 along the longitudinal direction.
  • the needle distal end portion 43 has a bending portion 44 that bends at least a portion of the needle distal end portion 43 so as to gradually move away from the central axis A of the outer cylinder 30 as it goes from the distal end of the needle main body portion 42 toward the opening 43a.
  • the line light L emitted from the irradiation unit 50 is applied to the surface of the living body S so as to overlap the plane passing through the central axis B of the injection needle 40. is irradiated from the bending direction side of the needle distal end portion 43 of the injection needle 40 inserted into.
  • This allows the operator to grasp the correct placement position of the ultrasound probe 200 with respect to the biological surface S. Therefore, if the operator arranges the wave transmission surface 210 of the ultrasonic probe 200 along the line light L, the operator can enter the irradiation area of the ultrasonic waves U emitted from the wave transmission surface 210 at least from the outer cylinder 30.
  • a needle tip 43 of the infusion needle 40 may be present. Therefore, the operator can easily confirm the bending direction and behavior of the injection needle 40 on the ultrasonic image, and can deliver the delivery product to the target site of the affected area.
  • the irradiating unit 50 includes a laser light source that irradiates a laser beam having a color complementary to that of the living body surface S as the line light L, and the line light L is emitted at an angle of 30 degrees or more. may be configured to be able to irradiate at an irradiation angle of .
  • the delivery device 100 configured in this way, by irradiating a laser beam having a complementary color to the biological surface S, such as green, as the line light L, the biological surface S having a three-dimensional gradient is irradiated. It becomes possible to irradiate the surface S with the line light L linearly.
  • the line light L by irradiating the line light L at an irradiation angle of 30 degrees or more, when the ultrasonic probe 200 is arranged on the surface S of the living body, the line light L having a sufficient length for alignment is applied to the living body.
  • the surface S can be irradiated.
  • the outer cylinder 30 may be configured to be rotatably held about the long axis of the first operation section 10 .
  • the delivery device 100 configured in this way, by rotatably attaching the outer cylinder 30 to the first operation part 10, when the injection needle 40 is rotated, the outer cylinder 30 does not rotate together.
  • the inserted state (insertion posture) is maintained. Therefore, the delivery device 100 can prevent damage due to friction with the surrounding living tissue that may occur due to the rotation of the outer cylinder 30 .
  • the irradiation unit 50 is a first irradiation capable of irradiating the line light L1 so as to overlap the plane passing through the central axis B of the injection needle 40 from the bending direction side of the needle tip portion 43. and a plane that passes through the central axis B of the injection needle 40 from the side opposite to the bending direction side of the needle tip portion 43 and which is a position radially facing the first irradiation position on the outer peripheral surface of the first operation portion 10 . may be configured to be arranged at the second irradiation positions where they can be irradiated with the line light L2.
  • the delivery device 100 configured in this way, when the operator inserts the delivery device 100 into the living body, the line light L1 emitted from the first irradiation position and the line light L2 emitted from the second irradiation position
  • the ultrasound probe 200 can be placed on the biological surface S along the . Both the line light L1 irradiated from the first irradiation position and the line light L2 irradiated from the second irradiation position are irradiated so as to overlap the plane passing through the central axis B of the injection needle 40 . Therefore, the operator has a higher degree of freedom in positioning the ultrasound probe 200, which facilitates treatment.
  • the second operation section 20 is attached so as to be rotatable in the circumferential direction with respect to the first operation section 10, and the irradiating section 50 rotates relative to the second operation section 20. It is good also as a structure provided so that it can follow.
  • the delivery device 100 configured in this way, when the injection needle 40 is rotated, the outer cylinder 30 is maintained in a state of being inserted into the living body (insertion posture), so that the rotation of the outer cylinder 30 causes It is possible to prevent damage due to friction with the surrounding living tissue.
  • the irradiation unit 50 rotates along with the rotation operation of the second operation unit 20 , the line light L can be irradiated following the bending direction of the needle distal end portion 43 of the injection needle 40 .
  • the irradiation section 50 has a first irradiation section 51 attached to the first operation section 10 and a second irradiation section 52 attached to the second operation section 20.
  • the first irradiation unit 51 and the second irradiation unit 52 in a state before the second operation unit 20 is rotated with respect to the first operation unit 10, the line light L3 irradiated from the first irradiation unit 51, It may be configured such that the line lights L4 emitted from the second irradiation unit 52 are attached to positions where they overlap on the living body surface S, respectively.
  • the operator before rotating the second operation unit 20, the operator places the ultrasonic probe 200 along the two line lights L3 and L4, When the bending direction of the injection needle 40 is changed by rotating the second operation unit 20 , the ultrasound probe 200 can be arranged along the line light L ⁇ b>4 emitted from the second irradiation unit 52 . Therefore, even when the operator rotates the second operation unit 20 to change the bending direction of the injection needle 40 , the operator can accurately grasp the arrangement position of the ultrasonic probe 200 .
  • the irradiation unit 50 includes the first line light LA for aligning the wave transmission surface 210 of the ultrasound probe 200 with respect to the biological surface S, and the first line light LA second line light beams LB (LB1, LB2) for adjusting the angle of the wave transmission surface 210 with respect to the living body surface S and positioned outside the first line light beam LA along both side edges of the good too.
  • the operator can place the ultrasound probe 200 on the first line light LA of the biological surface S so as not to overlap the second line light LB. , the ultrasound probe 200 can be positioned correctly. Further, when the ultrasound probe 200 is covered with the second line light LB (LB1 or LB2), the operator adjusts the inclination so that the ultrasound probe 200 is not covered with the second line light LB. By doing so, the ultrasonic probe 200 can be positioned correctly.
  • the second line light LB LB1 or LB2
  • a plurality of injection needles 40 are provided for the second operation section 20 , and the irradiation section 50 is provided in the second operation section 20 corresponding to each of the plurality of injection needles 40 . It is good also as a structure which attached multiple to the outer peripheral surface of.
  • the injection needle 40 is punctured at different positions of the affected area without rotating the second operation part 20 or rotating the delivery device 100 itself. be able to.
  • the irradiation unit 50 is provided for irradiating each of the injection needles 40 with the line light L so as to overlap the plane passing through the central axis B of the injection needle 40, the operator presses the injection needle 40 individually.
  • the ultrasonic probe 200 can be arranged along the line light L emitted from the corresponding irradiation unit 50 .
  • the outer surface of the distal end portion of the outer cylinder 30 and the outer surface of the needle distal end portion 43 of the injection needle 40 have a reflecting portion 60 for increasing the acoustic impedance difference with the surroundings. It is good also as a structure which has.
  • the delivery device 100 configured in this way, the visibility of the outer tube 30 and the injection needle 40 is improved on the ultrasound image, so that the operator can position the insertion position and the puncture site with respect to the affected part during insertion into the living body. becomes easier.
  • first operation unit 10 first operation unit, 20 second operation unit, 30 outer cylinder, 31 lumen of the barrel, 40 injection needle, 42 needle body, 43 needle tip, 44 bend, 50 irradiation unit, 51 first irradiation unit, 52 second irradiation unit, 60 Reflector, 100 delivery device; 200 ultrasonic probe, 210 transmission surface, L (L1 to L4) line light, LA first line light, LB second line light, A central axis of the outer cylinder, B central axis of injection needle (B1 central axis of needle main body, B2 central axis of needle tip), S biological surface, U Ultrasonic, Z central axis of the delivery device;

Landscapes

  • Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

Un dispositif d'administration 100, qui est destiné à l'administration d'un objet à administrer à une partie affectée dans un corps vivant, est pourvu : d'une première partie d'actionnement 10 ; d'un tube externe 30 qui a une lumière 31 et s'étend le long de la direction axiale longitudinale à partir de la pointe de la première partie d'actionnement 10 ; d'une seconde partie d'actionnement 20 qui est fixée à la première partie d'actionnement 10 d'une manière coulissante le long de la direction axiale longitudinale ; une aiguille d'injection 40 qui est logée de manière à effectuer un mouvement de va-et-vient dans la lumière 31 du tube externe 30 et s'étend le long de la direction axiale longitudinale à partir de la pointe de la seconde partie d'actionnement 10 ; et une partie d'irradiation 50 qui est fixée à la première partie de fonctionnement 10 et/ou à la seconde partie de fonctionnement 20 et irradie la lumière de ligne L, ladite lumière de ligne L chevauchant un plan passant par l'axe central de l'aiguille d'injection 40, à la surface S du corps vivant.
PCT/JP2022/009927 2021-03-25 2022-03-08 Dispositif d'administration WO2022202282A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2021-051369 2021-03-25
JP2021051369A JP2024063265A (ja) 2021-03-25 2021-03-25 送達デバイス

Publications (1)

Publication Number Publication Date
WO2022202282A1 true WO2022202282A1 (fr) 2022-09-29

Family

ID=83397082

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2022/009927 WO2022202282A1 (fr) 2021-03-25 2022-03-08 Dispositif d'administration

Country Status (2)

Country Link
JP (1) JP2024063265A (fr)
WO (1) WO2022202282A1 (fr)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004503291A (ja) * 2000-06-13 2004-02-05 エスディージーアイ・ホールディングス・インコーポレーテッド 経皮的注射針の位置決めシステム
JP2010115246A (ja) * 2008-11-11 2010-05-27 Hitachi Medical Corp 超音波探触子、及びその超音波探触子を用いた超音波診断装置
WO2012169178A1 (fr) * 2011-06-07 2012-12-13 富士フイルム株式会社 Dispositif et procédé de génération d'images photo-acoustiques

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004503291A (ja) * 2000-06-13 2004-02-05 エスディージーアイ・ホールディングス・インコーポレーテッド 経皮的注射針の位置決めシステム
JP2010115246A (ja) * 2008-11-11 2010-05-27 Hitachi Medical Corp 超音波探触子、及びその超音波探触子を用いた超音波診断装置
WO2012169178A1 (fr) * 2011-06-07 2012-12-13 富士フイルム株式会社 Dispositif et procédé de génération d'images photo-acoustiques

Also Published As

Publication number Publication date
JP2024063265A (ja) 2024-05-13

Similar Documents

Publication Publication Date Title
EP1351646B1 (fr) Dispositif pour la révascularisation myocardiale
JP3939360B2 (ja) エネルギー案内器具および案内方法
US8657749B2 (en) Ultrasonic puncture needle
US20060241342A1 (en) Optically guided penetration catheters and their methods of use
US10779807B2 (en) Steerable sheath tube and method for occluding atrial septal defect
US20090131790A1 (en) Systems and methods for deploying echogenic components in ultrasonic imaging fields
CN107072591A (zh) 与靶器官图像的治疗映射结合的医师控制的组织切除
EP1269931A1 (fr) Appareil d'irradiation médical
JP7440527B2 (ja) 角度付き腔内トランスデューサ用ニードルガイド
CA2863977C (fr) Dispositif d'ablation au laser pour ablation de tissus
WO2022202282A1 (fr) Dispositif d'administration
JP2002514461A (ja) 断層撮影法のための穿刺装置
CN210472242U (zh) 定位针、定位装置及定位设备
CN111936091A (zh) 眼科显微外科手术器械
US20210379395A1 (en) Treatment Method and Treatment System
US20230081294A1 (en) Stereotactic guidance device
JP7557405B2 (ja) 送達デバイス
JP2022149298A (ja) 医療器具
CN110169814B (zh) 定位针、定位装置、定位设备及定位方法
CN115363709A (zh) 一种可调弯的血管内超声引导式穿刺方法
JP2014176429A (ja) 経体腔式焼灼デバイス
JP2022149295A (ja) 送達デバイス
US10814128B2 (en) Electroporation catheter
JP2003190179A (ja) 超音波用穿刺針
JP2016202645A (ja) 超音波ガイド下穿刺術用の穿刺アダプター及び超音波診断装置

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 22775076

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 22775076

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: JP